Possible role of recombinant activated factor VII (RFVIIa) in the control of hemorrhage associated with massive trauma.
Martinowitz U, Kenet G, Lubetski A, Luboshitz J, Segal E
Can J Anaesth 2002;49(10):S15-S20.
Review by
Approaches to successful total knee arthroplasty in haemophilia A patients with inhibitors.
Konkle BA, Nelson C, Forsyth A, Hume E
Haemophilia 2002;8(5):706-710.
Review by Aldouri M
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I, Rodriguez-Merchan EC
Haemophilia 2002;8(3):288-291.
Review by
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U
Haemophilia 2001;7(5):517-522.
Review by M. Aldouri
Development of an animal model for assessment of the hemostatic efficacy of fibrin sealant in vascular surgery.
Kheirabadi BS, Pearson R, Rudnicka K, et al.
J Surg Res 2001;100(1):84-92.
Review by R. K. Spence
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659